• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用深度学习为局部晚期头颈部鳞状细胞癌患者提供个性化治疗建议。

Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning.

作者信息

Zhang Linmei, Zhu Enzhao, Shi Jiaying, Wu Xiao, Cao Shaokang, Huang Sining, Ai Zisheng, Su Jiansheng

机构信息

Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Tongji Research Institute of Stomatology, Department of Prosthodontics, Shanghai Tongji Stomatological Hospital, Dental School, Tongji University, Shanghai, China.

School of Medicine, Tongji University, Shanghai, China.

出版信息

Front Med (Lausanne). 2025 Jan 6;11:1478842. doi: 10.3389/fmed.2024.1478842. eCollection 2024.

DOI:10.3389/fmed.2024.1478842
PMID:39835092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11744519/
Abstract

BACKGROUND

The conventional treatment for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) is surgery; however, the efficacy of definitive chemoradiotherapy (CRT) remains controversial.

OBJECTIVE

This study aimed to evaluate the ability of deep learning (DL) models to identify patients with LA-HNSCC who can achieve organ preservation through definitive CRT and provide individualized adjuvant treatment recommendations for patients who are better suited for surgery.

METHODS

Five models were developed for treatment recommendations. Their performance was assessed by comparing the difference in overall survival rates between patients whose actual treatments aligned with the model recommendations and those whose treatments did not. Inverse probability treatment weighting (IPTW) was employed to reduce bias. The effect of the characteristics on treatment plan selection was quantified through causal inference.

RESULTS

A total of 7,376 patients with LA-HNSCC were enrolled. Balanced Individual Treatment Effect for Survival data (BITES) demonstrated superior performance in both the CRT recommendation (IPTW-adjusted hazard ratio (HR): 0.84, 95% confidence interval (CI), 0.72-0.98) and the adjuvant therapy recommendation (IPTW-adjusted HR: 0.77, 95% CI, 0.61-0.85), outperforming other models and the National Comprehensive Cancer Network guidelines (IPTW-adjusted HR: 0.87, 95% CI, 0.73-0.96).

CONCLUSION

BITES can identify the most suitable treatment option for an individual patient from the three most common treatment options. DL models facilitate the establishment of a valid and reliable treatment recommendation system supported by quantitative evidence.

摘要

背景

局部晚期头颈部鳞状细胞癌(LA-HNSCC)的传统治疗方法是手术;然而,根治性放化疗(CRT)的疗效仍存在争议。

目的

本研究旨在评估深度学习(DL)模型识别可通过根治性CRT实现器官保留的LA-HNSCC患者的能力,并为更适合手术的患者提供个性化辅助治疗建议。

方法

开发了五个用于治疗建议的模型。通过比较实际治疗与模型建议一致的患者和治疗不一致的患者之间的总生存率差异来评估其性能。采用逆概率处理加权(IPTW)来减少偏差。通过因果推断量化特征对治疗方案选择的影响。

结果

共纳入7376例LA-HNSCC患者。生存数据的平衡个体治疗效果(BITES)在CRT建议(IPTW调整后的风险比(HR):0.84,95%置信区间(CI),0.72-0.98)和辅助治疗建议(IPTW调整后的HR:0.77,95%CI,0.61-0.85)方面均表现出卓越性能,优于其他模型和美国国立综合癌症网络指南(IPTW调整后的HR:0.87,95%CI,0.73-0.96)。

结论

BITES可以从三种最常见的治疗方案中为个体患者确定最合适的治疗选择。DL模型有助于建立一个由定量证据支持的有效且可靠的治疗建议系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/fc4ce2f2aa35/fmed-11-1478842-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/b3c0ba3ccde9/fmed-11-1478842-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/d6506690103e/fmed-11-1478842-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/90712118534f/fmed-11-1478842-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/6afa78fe9883/fmed-11-1478842-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/c579b969f8ea/fmed-11-1478842-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/fc4ce2f2aa35/fmed-11-1478842-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/b3c0ba3ccde9/fmed-11-1478842-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/d6506690103e/fmed-11-1478842-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/90712118534f/fmed-11-1478842-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/6afa78fe9883/fmed-11-1478842-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/c579b969f8ea/fmed-11-1478842-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfa0/11744519/fc4ce2f2aa35/fmed-11-1478842-g0006.jpg

相似文献

1
Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning.利用深度学习为局部晚期头颈部鳞状细胞癌患者提供个性化治疗建议。
Front Med (Lausanne). 2025 Jan 6;11:1478842. doi: 10.3389/fmed.2024.1478842. eCollection 2024.
2
Tailoring nonsurgical therapy for elderly patients with head and neck squamous cell carcinoma: A deep learning-based approach.基于深度学习的方法:为老年头颈部鳞状细胞癌患者定制非手术治疗。
Medicine (Baltimore). 2024 Sep 13;103(37):e39659. doi: 10.1097/MD.0000000000039659.
3
Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer.深度学习指导下的老年乳腺癌患者辅助化疗选择。
Breast Cancer Res Treat. 2024 May;205(1):97-107. doi: 10.1007/s10549-023-07237-y. Epub 2024 Jan 31.
4
Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning.通过深度学习确定乳腺癌患者新辅助全身治疗的个体适用性。
Clin Transl Oncol. 2024 Oct;26(10):2584-2593. doi: 10.1007/s12094-024-03459-8. Epub 2024 Apr 28.
5
Quantified treatment effect at the individual level is more indicative for personalized radical prostatectomy recommendation: implications for prostate cancer treatment using deep learning.个体水平的量化治疗效果更能说明推荐行个体化根治性前列腺切除术的意义:深度学习在前列腺癌治疗中的应用。
J Cancer Res Clin Oncol. 2024 Feb 1;150(2):67. doi: 10.1007/s00432-023-05602-4.
6
Utilizing machine learning to tailor radiotherapy and chemoradiotherapy for low-grade glioma patients.利用机器学习为低级别胶质瘤患者定制放疗和放化疗方案。
PLoS One. 2024 Aug 20;19(8):e0306711. doi: 10.1371/journal.pone.0306711. eCollection 2024.
7
Optimizing adjuvant treatment options for patients with glioblastoma.优化胶质母细胞瘤患者的辅助治疗方案。
Front Neurol. 2024 Feb 21;15:1326591. doi: 10.3389/fneur.2024.1326591. eCollection 2024.
8
PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.PET-NECK:一项多中心随机III期非劣效性试验,比较正电子发射断层扫描-计算机断层扫描引导下的观察等待策略与计划性颈部清扫术在治疗头颈部鳞状细胞癌局部晚期(N2/N3)淋巴结转移中的效果。
Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170.
9
Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.表皮生长因子受体靶向治疗 III 期和 IV 期头颈部癌症。
Curr Oncol. 2010 Jun;17(3):37-48. doi: 10.3747/co.v17i3.520.
10
Individualized survival prediction and surgery recommendation for patients with glioblastoma.胶质母细胞瘤患者的个性化生存预测与手术建议
Front Med (Lausanne). 2024 May 9;11:1330907. doi: 10.3389/fmed.2024.1330907. eCollection 2024.

本文引用的文献

1
Lymph node yield: Impact on oncologic outcomes in oral cavity cancer.淋巴结获取量:对口腔癌肿瘤学结局的影响。
Head Neck. 2024 Aug;46(8):1965-1974. doi: 10.1002/hed.27656. Epub 2024 Feb 12.
2
Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.日本头颈部癌症患者的中期和长期生存亚部位特异性趋势:一项基于人群的研究。
Cancer Sci. 2024 Feb;115(2):623-634. doi: 10.1111/cas.16028. Epub 2023 Nov 23.
3
Lymph node ratio as a survival predictor for head and neck squamous cell carcinoma with multiple adverse pathological features.
淋巴结比率作为具有多种不良病理特征的头颈部鳞状细胞癌的生存预测指标。
Head Neck. 2023 Aug;45(8):2017-2027. doi: 10.1002/hed.27428. Epub 2023 Jun 9.
4
Is laterality in breast Cancer still worth studying? Local experience in Bahrain.乳腺癌的侧别研究还有价值吗?巴林的局部经验。
BMC Cancer. 2022 Sep 10;22(1):968. doi: 10.1186/s12885-022-10063-y.
5
Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis.在具有轻微风险因素的口腔癌术后放疗中添加同步化疗:文献系统评价与荟萃分析
Cancers (Basel). 2022 Jul 29;14(15):3704. doi: 10.3390/cancers14153704.
6
Prognostic value of lymph node involvement in oral squamous cell carcinoma.淋巴结浸润对口腔鳞状细胞癌的预后价值。
Clin Oral Investig. 2022 Nov;26(11):6711-6720. doi: 10.1007/s00784-022-04630-7. Epub 2022 Jul 27.
7
BITES: balanced individual treatment effect for survival data.BITEs:生存数据的平衡个体治疗效果。
Bioinformatics. 2022 Jun 24;38(Suppl 1):i60-i67. doi: 10.1093/bioinformatics/btac221.
8
Advances in Organ Preservation for Laryngeal Cancer.喉癌的器官保存进展。
Curr Treat Options Oncol. 2022 Apr;23(4):594-608. doi: 10.1007/s11864-022-00945-5. Epub 2022 Mar 18.
9
NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.NCCN 指南®洞察:头颈部癌症,第 1.2022 版。
J Natl Compr Canc Netw. 2022 Mar;20(3):224-234. doi: 10.6004/jnccn.2022.0016.
10
Marital status and survival in laryngeal squamous cell carcinoma patients: a multinomial propensity scores matched study.婚姻状况与喉鳞癌患者生存的关系:一项多分类倾向评分匹配研究。
Eur Arch Otorhinolaryngol. 2022 Jun;279(6):3005-3011. doi: 10.1007/s00405-022-07252-7. Epub 2022 Jan 16.